Search Results - "M.A. Duran"

PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA) by Matheus, W, Duran, M.A, Clark, O.A.C, Kumar, A, Ferreira, U, Botrel, T.E.A

Get full text

PP439 Topic: AS15–Lung: Respiratory Support/Acute Respiratory Failure/Other: FACTORS ASSOCIATED WITH THE FAILURE OF HIGH-FLOW NASAL CANNULAS IN A MEXICAN PEDIATRIC INTENSIVE CARE UNIT by Lopez Alamilla, Alexis Amado, Ventura Gomez, S.T., Maldonado Cisneros, A., Sanchez Duran, M.A., Martinez Jasso, G.

Get full text

2371P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts) by Gupta, S., Climent Duran, M.A., Sridhar, S., Powles, T.B., Bellmunt, J., Tyroller, K., Guenther, S., di Pietro, A., Grivas, P.

Get full text

Abdomen agudo in utero, gastrosquisis etiológica y consumo de cocaína materna. Reporte de caso by Juárez Azpilcueta, A, Rivera, A.M, Islas, L.P, Duran, M.A, Tellez, S.E

“…Resumen El onfalocele y la gastrosquisis son defectos de la pared abdominal (DPA) más frecuentes. Ambos necesitan un diagnóstico precoz y tratamiento…”
Get full text

2366P Phase I-II study of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial) by Castellano Gauna, D.E., Duran Martinez, I., Mellado Gonzalez, B., Climent Duran, M.A., Garcia Del Muro, X., Sala González, N., Alonso Gordoa, T., Sevillano Fernandez, E., Domenech Santasusana, M., Paramio, J., Real, F.X., Malats, N., Font Pous, A.

Get full text

Neurocisticercosis en el embarazo by Juarez, A, Rivera, A.M, Contreras, O, Tellez, S.E, Duran, M.A, Islas, L.P

“…Resumen La NCC constituye la parasitosis más común del cerebro y uno de los problemas neurológicos más frecuentes entre la población de México y otros países…”
Get full text

1791P Molecular profiling and prognostic relevance of low PTEN expression in metastatic hormone-sensitive prostate cancer patients by Garcia De Herreros, M., Jimenez Blasco, N., Reig Torras, O., Ruiz de Porras, V., Pardo, J.C., Font Pous, A., Aversa, C., Ferrer-Mileo, L., Jorda, M., Rodríguez-Carunchio, L., Trias Puigsureda, I., Sánchez-Font, A., Rodriguez-Vida, A., Domenech Santasusana, M., Figols Gorina, M., Climent Duran, M.A., Chirivella Gonzalez, I., Herrero Rivera, D., Gonzalez Billalabeitia, E., Mellado Gonzalez, B.

Get full text

1783P PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase by Arranz Arija, J.A., Piulats Rodriguez, J.M., Vazquez Estevez, S., Sepúlveda Sánchez, J.M., Alonso Gordoa, T., Perez Valderrama, B., Sala González, N., Climent Duran, M.A., Gallardo Diaz, E., Rodriguez-Vida, A., Caballero Diaz, C., Puente, J., Mendez Vidal, M.J., Parra, E.M.F., Martín, R.C., Virizuela Echaburu, J.A., Gragera, M.B.G., García Sanchez, J., García-Carbonero, I., Carles Galceran, J.

Get full text

1793P PPROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Safety and toxicity profiles from the pilot phase by Arranz Arija, J.A., Vazquez Estevez, S., Alonso Gordoa, T., Sepúlveda Sánchez, J.M., Perez Valderrama, B., Climent Duran, M.A., Gallardo Diaz, E., Lázaro Quintela, M., Lainez Milagro, N., Domenech Santasusana, M., Gonzalez del Alba Baamonde, M.A., Abad Villar, M.T., Crespo Herrero, G., Alvarez Fernandez, C., Mellado Gonzalez, B., Zambrana Tevar, F.J., Lopez Lopez, C., Perez Ramirez, S., Villa Guzmán, J.C., Piulats Rodriguez, J.M.

Get full text

Necrotising enterocolitis: Case series of General Hospital of Mexico “Dr. Eduardo Liceaga” by Sansón-Riofrío, L, Chávez-Gómez, V.R, Peralta-Álvarez, M.P, Durán-Padilla, M.A

“…Abstract Background Necrotising enterocolitis (NEC) is an acute inflammatory condition of the colon involving a wide range of diseases with one end result:…”
Get full text

1448O Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) + lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC) by Albiges, L., Gurney, H.P., Atduev, V., Suárez, C., Climent Duran, M.A., Pook, D., Tomczak, P., Barthelemy, P., Lee, J-L., Nalbandian, T., Stus, V., Ferguson, T., Wiechno, P., Gokmen, E., Lacombe, L., Gedye, C., Perini, R., Sharma, M., C. Li, Lee, C-H.

Get full text

1747P Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study by De Wit, R., Vaughn, D.J., Fradet, Y., Fong, L., Vogelzang, N.J., Climent Duran, M.A., Necchi, A., Petrylak, D.P., Gerritsen, W.R., Gurney, H.P., Quinn, D.I., Culine, S., Sternberg, C.N., Bajorin, D.F., Choueiri, T.K., Xu, J., Imai, K., Homet Moreno, B., Bellmunt, J., Lee, J-L.

Get full text

Efecto teratogénico por quimioterapia en cáncer mamario? by Juárez, A, Rivera, A.M, Islas, L.P, Duran, M.A, Tellez, S.E, Cruz, J, Alarcón, I

“…Resumen El cáncer de mama durante el embarazo es una circunstancia clínica infrecuente. Esta asociación plantea interrogantes en lo referente al manejo de la…”
Get full text

745P Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC) by Powles, T.B., Kopyltsov, E., Su, P-J., Parnis, F.X., Park, S.H., Yamamoto, Y., Fong, P.C., Tournigand, C., Climent Duran, M.A., Bamias, A., Caserta, C., Chang, J., Yan, E., di Pietro, A., Wang, J., Grivas, P.

Get full text

803TiP Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients by Climent Duran, M.A., Basterretxea, L., Sanchez Escribano, R., Llabres, E., Heras Lopez, L., Zambrana, F., Torregrosa, M.D., Girones Sarrio, R., Villa Guzman, J.C., Juan Fita, M.J., Fernandez Nuñez, N.

Get full text

Hernia inguinal y umbilical durante la gestación, análisis perinatal y resolución quirúrgica by Juárez, A.A, Rivera, A.M, Islas, L.P, Duran, M.A, Tellez, S.E, Cruz, J, Alarcón, I

“…Resumen Las hernias inguinales y umbilicales durante el embarazo presentan un problema clínico frecuente, el contenido herniario puede complicar el embarazo y…”
Get full text

625P TMPRSS2-ERG expression and clinical evolution of metastatic hormone sensitive prostate cancer by Aversa, C., Jimenez, N., Marín-Aguilera, M., Ferrer, L., Rodríguez-Carunchio, L., Diaz-Mercedes, S., Font Pous, A., Rodriguez-Vida, A., Domenech Santasusana, M., Figols Gorina, M., Climent Duran, M.A., Cros Costa, S., Chirivella, I., Herrero Rivera, D., Gonzalez-Billalabeitia, E., Jiménez-Peralta, D., Carles Galceran, J., Suarez Rodriguez, C., Reig Torras, O., Mellado, B.

Get full text

666P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC): Results after a minimum of 41 months of follow-up from KEYNOTE-427 cohort A by McDermott, D.F., Lee, J-L., Bjarnason, G.A., Larkin, J., Gafanov, R., Kochenderfer, M.D., Jensen, N.V., Donskov, F., Malik, J., Poprach, A., Tykodi, S.S., Alonso-Gordoa, T., Cho, D.C., Geertsen, P.F., Climent Duran, M.A., Di Simone, C., Liu, H., Burgents, J., Rodriguez-Lopez, K., Atkins, M.B.

Get full text

1572P The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study by Duran, M.A. Climent, Vidal, N., Pérez, S., Méndez-Vidal, M.J., Anguera, G., Salas, I. Martinez, Gallardo, E., Cuellar, M.A., Soto, J.J., Martín, A., Domènech, M., Rodriguez-Vida, A., Casado, E. Almagro, Diaz-Mejía, N., Kareaga, M. Martinez, Calvo, O. Fernandez, Guzmán, J.C. Villa, Vazquez, S., Gonzalez del Alba, A., Puente, J.

Get full text

589P Dynamics of peripheral blood immune profiling associated with tumour progression in metastatic castration resistant prostate cancer (mCRPC) by Perez Navarro, E., Conteduca, V., Gonzalez del Alba, A., Mellado, B., Cremaschi, P., Fernandez Calvo, O., Mendez Vidal, M.J., Climent Duran, M.A., Duran, I., Gallardo Diaz, E., Vazquez, S., Font Pous, A., Gurioli, G., Martínez, A., López Andreo, M.J., Attard, G., Castellano Gauna, D., Grande, E., Giorgi, U., Gonzalez Billalabeitia, E.

Get full text